High Vista Strategies LLC Pliant Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $255 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.85 - $19.15 $42,610 - $63,501
3,316 Added 10.79%
34,039 $616,000
Q3 2023

Nov 14, 2023
SELL
$14.58 - $20.15 $48,288 - $66,736
-3,312 Reduced 9.73%
30,723 $532,000
Q1 2023

May 15, 2023
SELL
$18.73 - $36.26 $139,107 - $269,303
-7,427 Reduced 17.91%
34,035 $905,000
Q4 2022

Feb 14, 2023
BUY
$17.0 - $25.43 $704,854 - $1.05 Million
41,462 New
41,462 $801,000

Others Institutions Holding PLRX

# of Institutions
168
Shares Held
63.2M
Call Options Held
245K
Put Options Held
373K
View Full List

About PLIANT THERAPEUTICS, INC.

PLRX Quotes by TradingView
  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email